南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停

通过功能性超分子脂质纳米颗粒协同抑制外泌体分泌及沉默PD-L1,增强抗肿瘤免疫效应

Synergistic inhibition of exosome secretion and PD-L1 silence via a functional supramolecular lipid nanoparticle to boost antitumor immunity

Jiayi Men, Xueyan Zhang, Wenjie Zhang, Xiaomin Gao, Meiqi Cheng, Xinyang Yu, Shaolong Qi

Journal:JOURNAL OF CONTROLLED RELEASE

IF:12.4

DOI:10.1016/j.jconrel.2026.115331

PMID:

Published:2026-09-03

research field:界面科学等离子体医学流体力学等离子体物理生物物理学

Abstract

The treatment of malignancies remains a formidable challenge, driven by the complex interplay of exosome-mediated metastasis and PD-L1-driven immune evasion. Overcoming these barriers through simultaneous modulation of both pathways represents a critical, yet unmet, need in cancer therapy. To address this, we engineer a supramolecular lipid nanoparticle (LNP) wherein lipid-modified cyclodextrin and oxaliplatin (OxPt-2PA) synergize as both a delivery vector and an immunogenic cell death inducer. Leveraging multiple supramolecular interactions, this platform co-encapsulates the exosome inhibitor Nexinhib20 and small interfering RNA targeting PD-L1 (siPD-L1), orchestrating a multi-pronged attack on tumor progression and immunosuppression. In vivo , this therapeutic strategy markedly enhances dendritic cells maturation, promotes cytotoxic T cell infiltration and significantly suppresses both primary tumor growth and distant metastasis. This work establishes a chemotherapy-induced supramolecular integrated co-delivery platform that simultaneously counteracts metastasis and immunosuppression via “drug-and-gene” therapy, offering a promising strategy for the treatment of aggressive cancer.

本文使用的Yeasen产品

相关产品
购物车
客服
转染试用